Does urinary mycotoxin detection identify the source of exposure?

Urinary mycotoxin testing can document an analyte in urine, but its clinical and environmental interpretation is narrowly constrained. For this 50-year-old woman, a positive result should not be treated as proof of a mold-contaminated home/workplace, a dietary source, chronic exposure, or mycotoxin-related illness.

Clinical and exposure evidence

• Validated LC–MS/MS detection of a mycotoxin or relevant metabolite is biologically consistent with internal exposure, especially for ochratoxin A (OTA) and, less definitively, nivalenol. In one LC–MS/MS biomonitoring study, nivalenol was detected in 53% of 89 adult urine samples.
• Dietary exposure is a major alternative explanation: healthy people may have detectable urinary mycotoxins after consuming contaminated foods. CDC notes that a positive urine result cannot establish where exposure occurred, and no urine concentration predicts illness.
• Interpretation is assay- and toxin-specific. There is no presented human urinary-biomonitoring validation for roridin L2 or verrucarin J.

Mechanistic and timing considerations

• Urinary concentrations reflect absorption, metabolism, renal excretion, urine dilution, and sample timing—not simply environmental burden. Spot urine is therefore principally a marker of relatively recent internal exposure; raw and creatinine-adjusted results may both be informative, although creatinine is physiologically variable.
• Elimination windows differ substantially. Much ingested deoxynivalenol is excreted within 24–48 hours, whereas OTA can be eliminated more slowly. A single result consequently cannot distinguish recent dietary intake, continuing exposure, or an indeterminate residual signal from earlier exposure.
• For OTA, only a small fraction of an ingested dose is excreted unchanged in urine, limiting inference about dose or habitual intake.

Practical implications

• Small, uncontrolled paired building–urine studies, including a two-worker damp-workplace pilot, do not validate source attribution. When a building is suspected, assessment should focus on dampness, water damage, and contaminated materials rather than urine testing alone.

Bottom line

• Urinary mycotoxin detection plausibly indicates exposure when analytically validated, but it cannot by itself identify an ongoing mold-contaminated building, diet, or historical exposure.